Mitoxantrone - Concentrate 2 mg / mL Injection 10 mL
Reference details for licensed healthcare facility review and verification.
| NDC 11 | 61703-0343-18 |
|---|---|
| Product NDC | 61703-0343 |
| Generic Drug Name | Mitoxantrone Concentrate |
| Brand Name | Mitoxantrone |
| Manufacturer | Hospira, Inc. |
| Strength | 2 mg / mL |
| Dosage Form | Injection |
| Drug Type | Intravenous |
| Package Quantity | 1 Vial, Multi-Dose |
| Package Description | 1 VIAL, MULTI-DOSE in 1 CARTON (61703-343-18) / 10 mL in 1 VIAL, MULTI-DOSE |
| Active Ingredients | Mitoxantrone Hydrochloride |
| Marketing Category | ANDA |
Unless explicitly stated in writing, no direct affiliation, sponsorship, or endorsement by individual product manufacturers with Premium Rx National, LLC should be implied. All brand names, trade names, and trademarks are the property of their respective owners and are presented solely for accurate product identification and informational reference.
NDC snapshot
Mitoxantrone Concentrate 2 mg / mL Injection is tracked under NDC 61703-0343-18 and rolls up into product family 61703-0343. Use this page to review package-level identifiers before comparing related family pages or starting a quote review.
- Package configuration: 1 Vial, Multi-Dose.
- Manufacturer: Hospira, Inc..
- Dosage form: Injection.
- Family size: 3 indexed presentations.
Click a tag to refine the catalog view around this product reference.
Official references
Use official labeling and directory references to confirm presentation details while your team reviews the PRN catalog entry and related sourcing paths.
Alternate presentations in this family
These nearby package-level pages can help healthcare teams compare related packaging or presentation differences inside the same product-NDC family.
Potential alternatives with matching presentation
Open the comparison hub or review package-level listings from 2 product-NDC families with matching normalized presentation details. Review each product detail page before treating any item as a true alternative.
View Potential Alternative HubmitoXANTRONE Concentrate 2 mg / mL Injection 10 mL Vial2 package-level listings in the comparison hub.Sample package-level pages in this comparison set
Drug Shortage Information
Public sources provide strong public references for the exact mitoxantrone product and its FDA/manufacturer history.
Drug Shortage Index family
View Mitoxantrone Concentrate in the Drug Shortage IndexCompare related NDC-level product references and family-level shortage context for Mitoxantrone Concentrate.This section is intended to help healthcare teams review public shortage history and related availability references for this product. Supply conditions can change quickly across manufacturers, distributors, and care settings, and these references may not reflect the latest market status. Premium Rx National does not guarantee completeness or suitability for clinical, operational, or purchasing decisions. Please confirm current availability with FDA, manufacturers, and other authoritative sources before relying on this information.
Mitoxantrone - Concentrate 2 mg / mL Injection 10 mL, NDC 61703-0343-18, is a Hospira, Inc. 2 mg / mL injection presentation packaged as 1 Vial, Multi-Dose. Historical public shortage information is available for this product reference.
NDC search formats
- Canonical NDC 11: 61703-0343-18
- Digits-only NDC 11: 61703034318
- Possible 10-digit display format: 61703-343-18 (6170334318)
Helpful product links
- Search by brand name: Mitoxantrone
- NDC 11: 61703-0343-18
- Product family NDC: 61703-0343
- Compare related presentations: Mitoxantrone - Concentrate 2 mg / mL Injection 12.5 mL, Mitoxantrone - Concentrate 2 mg / mL Injection 15 mL
- VA classification code: AN900
- VA classification code description: ANTINEOPLASTIC,OTHER
- CMOP ID: M1265
- VUID: 4009158